Lilly’s $400 Billion Surge Reshapes Big Pharma, Rally
Eli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
Recognize warning signs your budget is bad and learn practical tweaks to restore balance and reliability.
19,039 articlesEli Lilly has added roughly $400 billion in market value over the past year, fueling a dramatic shift in Big Pharma a...
XRP sits in a tight range around $1.10 as traders await regulatory developments. A clean break above $1.20 could redr...
Stablecoin market cap has fallen by more than $10 billion since May as investors rotate into memecoins. Bitcoin and E...
The White House announced a renewed naval blockade of Iranian shipping through the Strait of Hormuz and a 20% toll on...
Meta's push into cloud services could reshape AI compute bets. Learn how Nebius and CoreWeave investors might respond...
BitMine posted a strong ETH staking quarter, but a large derivatives loss erased gains, underscoring risk in its Ethe...
Lucid shares rebound for a second day after the CEO refutes bankruptcy and take-private rumors, with investors eyeing...
SpaceX’s IPO frenzy has cooled, dragging crypto-linked bets with it. A looming unlock window, plus a sharp pullback i...
Ryanair's chief financial officer says a winter shakeout could leave weaker rivals behind, boosting pricing power for...
Garmin delivered a dominant Q4 with a big EPS beat and revenue surge, triggering a sharp market rally as investors we...
Outdoor gear players are showing renewed momentum as travel and camping trends rebound. This piece analyzes the leade...
The BEA reports the U.S. economy expanded at a 1.4% annualized rate in Q4, far below economists' 3% projection. The s...